Siemens Healthcare Diagnostics is recalling 15,405 kits of ADVIA Centaur and Atellica IM aTPO Assays due to a technical defect where testing lots may show incorrectly high (positive bias) results for patients. This issue specifically affects results at or below the 60 U/mL threshold when compared to other testing lots. If you have had blood work performed using these specific diagnostic kits, the results regarding thyroid antibodies may be inaccurate, potentially leading to incorrect medical conclusions. Consumers should contact their healthcare provider to discuss whether re-testing is necessary using unaffected lots.
The assays may report falsely elevated thyroid antibody levels, which could lead to a misdiagnosis of autoimmune thyroid disease or inappropriate clinical management. While no specific injuries were reported in the data, the 'positive bias' means a patient might be told they have a condition that is not actually present or is less severe than indicated.
Manufacturer notification and potential replacement
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.